Global Pharmaceuticals and Biotechnology R&D Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pharmaceuticals and Biotechnology R&D Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Pharmaceuticals and Biotechnology R&D Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Drug
  • 1.4.3 Medical Equipment
  • 1.4.4 Vaccine
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Pharmaceuticals and Biotechnology R&D Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Homecare
  • 1.5.5 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceuticals and Biotechnology R&D Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Pharmaceuticals and Biotechnology R&D Industry
    • 1.6.1.1 Pharmaceuticals and Biotechnology R&D Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Pharmaceuticals and Biotechnology R&D Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Pharmaceuticals and Biotechnology R&D Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Pharmaceuticals and Biotechnology R&D Market Perspective (2015-2026)
• 2.2 Pharmaceuticals and Biotechnology R&D Growth Trends by Regions
  • 2.2.1 Pharmaceuticals and Biotechnology R&D Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmaceuticals and Biotechnology R&D Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pharmaceuticals and Biotechnology R&D Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pharmaceuticals and Biotechnology R&D Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmaceuticals and Biotechnology R&D Players by Market Size
  • 3.1.1 Global Top Pharmaceuticals and Biotechnology R&D Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pharmaceuticals and Biotechnology R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pharmaceuticals and Biotechnology R&D Market Concentration Ratio
  • 3.2.1 Global Pharmaceuticals and Biotechnology R&D Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pharmaceuticals and Biotechnology R&D Revenue in 2019
• 3.3 Pharmaceuticals and Biotechnology R&D Key Players Head office and Area Served
• 3.4 Key Players Pharmaceuticals and Biotechnology R&D Product Solution and Service
• 3.5 Date of Enter into Pharmaceuticals and Biotechnology R&D Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Pharmaceuticals and Biotechnology R&D Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Type (2021-2026)

5 Pharmaceuticals and Biotechnology R&D Breakdown Data by Application (2015-2026)

• 5.1 Global Pharmaceuticals and Biotechnology R&D Market Size by Application (2015-2020)
• 5.2 Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmaceuticals and Biotechnology R&D Market Size (2015-2020)
• 6.2 Pharmaceuticals and Biotechnology R&D Key Players in North America (2019-2020)
• 6.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2015-2020)
• 6.4 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pharmaceuticals and Biotechnology R&D Market Size (2015-2020)
• 7.2 Pharmaceuticals and Biotechnology R&D Key Players in Europe (2019-2020)
• 7.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2015-2020)
• 7.4 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2015-2020)

8 China

• 8.1 China Pharmaceuticals and Biotechnology R&D Market Size (2015-2020)
• 8.2 Pharmaceuticals and Biotechnology R&D Key Players in China (2019-2020)
• 8.3 China Pharmaceuticals and Biotechnology R&D Market Size by Type (2015-2020)
• 8.4 China Pharmaceuticals and Biotechnology R&D Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pharmaceuticals and Biotechnology R&D Market Size (2015-2020)
• 9.2 Pharmaceuticals and Biotechnology R&D Key Players in Japan (2019-2020)
• 9.3 Japan Pharmaceuticals and Biotechnology R&D Market Size by Type (2015-2020)
• 9.4 Japan Pharmaceuticals and Biotechnology R&D Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size (2015-2020)
• 10.2 Pharmaceuticals and Biotechnology R&D Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size by Application (2015-2020)

11 India

• 11.1 India Pharmaceuticals and Biotechnology R&D Market Size (2015-2020)
• 11.2 Pharmaceuticals and Biotechnology R&D Key Players in India (2019-2020)
• 11.3 India Pharmaceuticals and Biotechnology R&D Market Size by Type (2015-2020)
• 11.4 India Pharmaceuticals and Biotechnology R&D Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Pharmaceuticals and Biotechnology R&D Market Size (2015-2020)
• 12.2 Pharmaceuticals and Biotechnology R&D Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Pharmaceuticals and Biotechnology R&D Market Size by Type (2015-2020)
• 12.4 Central & South America Pharmaceuticals and Biotechnology R&D Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 ROCHE
  • 13.1.1 ROCHE Company Details
  • 13.1.2 ROCHE Business Overview and Its Total Revenue
  • 13.1.3 ROCHE Pharmaceuticals and Biotechnology R&D Introduction
  • 13.1.4 ROCHE Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020))
  • 13.1.5 ROCHE Recent Development
• 13.2 JOHNSON & JOHNSON
  • 13.2.1 JOHNSON & JOHNSON Company Details
  • 13.2.2 JOHNSON & JOHNSON Business Overview and Its Total Revenue
  • 13.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Introduction
  • 13.2.4 JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.2.5 JOHNSON & JOHNSON Recent Development
• 13.3 MERCK
  • 13.3.1 MERCK Company Details
  • 13.3.2 MERCK Business Overview and Its Total Revenue
  • 13.3.3 MERCK Pharmaceuticals and Biotechnology R&D Introduction
  • 13.3.4 MERCK Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.3.5 MERCK Recent Development
• 13.4 NOVARTIS
  • 13.4.1 NOVARTIS Company Details
  • 13.4.2 NOVARTIS Business Overview and Its Total Revenue
  • 13.4.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Introduction
  • 13.4.4 NOVARTIS Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.4.5 NOVARTIS Recent Development
• 13.5 PFIZER
  • 13.5.1 PFIZER Company Details
  • 13.5.2 PFIZER Business Overview and Its Total Revenue
  • 13.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Introduction
  • 13.5.4 PFIZER Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.5.5 PFIZER Recent Development
• 13.6 SANOFI
  • 13.6.1 SANOFI Company Details
  • 13.6.2 SANOFI Business Overview and Its Total Revenue
  • 13.6.3 SANOFI Pharmaceuticals and Biotechnology R&D Introduction
  • 13.6.4 SANOFI Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.6.5 SANOFI Recent Development
• 13.7 BAYER
  • 13.7.1 BAYER Company Details
  • 13.7.2 BAYER Business Overview and Its Total Revenue
  • 13.7.3 BAYER Pharmaceuticals and Biotechnology R&D Introduction
  • 13.7.4 BAYER Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.7.5 BAYER Recent Development
• 13.8 BRISTOL-MYERS SQUIBB
  • 13.8.1 BRISTOL-MYERS SQUIBB Company Details
  • 13.8.2 BRISTOL-MYERS SQUIBB Business Overview and Its Total Revenue
  • 13.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Introduction
  • 13.8.4 BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.8.5 BRISTOL-MYERS SQUIBB Recent Development
• 13.9 ASTRAZENECA
  • 13.9.1 ASTRAZENECA Company Details
  • 13.9.2 ASTRAZENECA Business Overview and Its Total Revenue
  • 13.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Introduction
  • 13.9.4 ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.9.5 ASTRAZENECA Recent Development
• 13.10 GLAXOSMITHKLINE
  • 13.10.1 GLAXOSMITHKLINE Company Details
  • 13.10.2 GLAXOSMITHKLINE Business Overview and Its Total Revenue
  • 13.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Introduction
  • 13.10.4 GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 13.10.5 GLAXOSMITHKLINE Recent Development
• 13.11 ABBVIE
  • 10.11.1 ABBVIE Company Details
  • 10.11.2 ABBVIE Business Overview and Its Total Revenue
  • 10.11.3 ABBVIE Pharmaceuticals and Biotechnology R&D Introduction
  • 10.11.4 ABBVIE Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.11.5 ABBVIE Recent Development
• 13.12 ELI LILLY
  • 10.12.1 ELI LILLY Company Details
  • 10.12.2 ELI LILLY Business Overview and Its Total Revenue
  • 10.12.3 ELI LILLY Pharmaceuticals and Biotechnology R&D Introduction
  • 10.12.4 ELI LILLY Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.12.5 ELI LILLY Recent Development
• 13.13 BOEHRINGER SOHN
  • 10.13.1 BOEHRINGER SOHN Company Details
  • 10.13.2 BOEHRINGER SOHN Business Overview and Its Total Revenue
  • 10.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Introduction
  • 10.13.4 BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.13.5 BOEHRINGER SOHN Recent Development
• 13.14 AMGEN
  • 10.14.1 AMGEN Company Details
  • 10.14.2 AMGEN Business Overview and Its Total Revenue
  • 10.14.3 AMGEN Pharmaceuticals and Biotechnology R&D Introduction
  • 10.14.4 AMGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.14.5 AMGEN Recent Development
• 13.15 GILEAD SCIENCES
  • 10.15.1 GILEAD SCIENCES Company Details
  • 10.15.2 GILEAD SCIENCES Business Overview and Its Total Revenue
  • 10.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Introduction
  • 10.15.4 GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.15.5 GILEAD SCIENCES Recent Development
• 13.16 TAKEDA PHARMACEUTICAL
  • 10.16.1 TAKEDA PHARMACEUTICAL Company Details
  • 10.16.2 TAKEDA PHARMACEUTICAL Business Overview and Its Total Revenue
  • 10.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Introduction
  • 10.16.4 TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.16.5 TAKEDA PHARMACEUTICAL Recent Development
• 13.17 NOVO NORDISK
  • 10.17.1 NOVO NORDISK Company Details
  • 10.17.2 NOVO NORDISK Business Overview and Its Total Revenue
  • 10.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Introduction
  • 10.17.4 NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.17.5 NOVO NORDISK Recent Development
• 13.18 BIOGEN
  • 10.18.1 BIOGEN Company Details
  • 10.18.2 BIOGEN Business Overview and Its Total Revenue
  • 10.18.3 BIOGEN Pharmaceuticals and Biotechnology R&D Introduction
  • 10.18.4 BIOGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.18.5 BIOGEN Recent Development
• 13.19 ABBOTT
  • 10.19.1 ABBOTT Company Details
  • 10.19.2 ABBOTT Business Overview and Its Total Revenue
  • 10.19.3 ABBOTT Pharmaceuticals and Biotechnology R&D Introduction
  • 10.19.4 ABBOTT Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.19.5 ABBOTT Recent Development
• 13.20 ASTELLAS PHARMA
  • 10.20.1 ASTELLAS PHARMA Company Details
  • 10.20.2 ASTELLAS PHARMA Business Overview and Its Total Revenue
  • 10.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Introduction
  • 10.20.4 ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.20.5 ASTELLAS PHARMA Recent Development
• 13.21 TEVA PHARMACEUTICAL INDUSTRIES
  • 10.21.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details
  • 10.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview and Its Total Revenue
  • 10.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Introduction
  • 10.21.4 TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R&D Business (2015-2020)
  • 10.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer